(19)
(11) EP 1 194 544 A1

(12)

(43) Date of publication:
10.04.2002 Bulletin 2002/15

(21) Application number: 00941478.0

(22) Date of filing: 16.06.2000
(51) International Patent Classification (IPC)7C12N 15/12, C12N 15/63, C12N 15/62, C12N 15/67, C12N 15/86, C07K 14/47, A01K 67/027, A61K 48/00
(86) International application number:
PCT/US0016/620
(87) International publication number:
WO 0078/951 (28.12.2000 Gazette 2000/52)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 18.06.1999 US 140289 P

(71) Applicant: ARIAD GENE THERAPEUTICS, INC.
Cambridge, MA 02139-4234 (US)

(72) Inventor:
  • NATESAN, Sridaran
    Chestnut Hill, MA 02167 (US)

(74) Representative: VOSSIUS & PARTNER 
Siebertstrasse 4
81675 München
81675 München (DE)

   


(54) CHIMERIC OCA-B TRANSCRIPTION FACTORS